Search for a command to run...
Anuh Pharma Ltd. is currently lagging behind its peers in key financial metrics. While it shows no significant debt, its lack of growth and profitability metrics indicates a need for improvement. In contrast, companies like Sun Pharmaceuticals and Dr. Reddy's Laboratories exhibit strong growth and profitability, making them sector leaders. Anuh Pharma's current valuation appears attractive, but without evident growth, it may not be a compelling investment at this time.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
ANUHPHR | ₹87.34 | ₹437.68Cr | 18.49 | - | - |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |